Head-to-head · Cost-Efficiency Index
Clume Health vs Nova
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Clume Health
Readers who want the dispensing pharmacies named up front and do not need the price broken out by molecule.
Visit Clume HealthNova
Readers who want the membership inside the quoted price rather than added to it, and who want a daily sublingual option beside the injection.
Visit NovaThe verdict
Clume Health takes it, leading the Cost-Efficiency Index 73 to 72. Clume Health charges one $259 monthly price for its Signature program whichever GLP-1 a provider picks and whichever route you take, names its four dispensing pharmacies with addresses, and advertises a $199 figure that matches nothing it sells. Nova still earns a C — Readers who want the membership inside the quoted price rather than added to it, and who want a daily sublingual option beside the injection.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Clume Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Clume Health | Nova |
|---|---|---|
| Cost-Efficiency Index | 73/100 | 72/100 |
| Semaglutide / mo | $259/month month-to-month (one Signature price covers semaglutide or tirzepatide, oral or injectable; $186/mo needs a 52-week plan) | $198/mo month-to-month all-in (medication plus the $99/mo membership; a "Starting at" floor that rises with dose) |
| Tirzepatide / mo | $259/month month-to-month (the same Signature price; $186/mo needs a 52-week plan) | $210/mo month-to-month all-in (same bundle; also a "Starting at" floor) |
| Semaglutide / yr (modeled) | $3,108 | $2,376 |
| Tirzepatide / yr (modeled) | $3,108 | $2,520 |
| Coverage | All 50 states | 49 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #66 | #72 |
Clume Health
73/100Where the value is
- Names all four dispensing pharmacies with street addresses, phone numbers and websites, so a buyer can look up who actually compounds the prescription
- The price is published before the intake and covers the consultation, ongoing oversight, the medication and delivery
- One figure covers semaglutide, tirzepatide, oral and injectable, so switching molecule or route does not change the bill
The tradeoffs
- Both headline prices on the homepage match nothing on sale: "*$199/month" against real floors of $259 and $219, and "*$159/month" against $216 — and neither asterisk resolves to a footnote
- The cheaper monthly figures are commitments rather than rates: $186 a month requires a 52-week plan and $200 a month a 12-week one
Nova
72/100Where the value is
- Quotes one all-in figure that already contains the $99 monthly membership, the medication and refrigerated shipping, so the membership is not a surprise at checkout
- Names a medical director and a nurse practitioner with credentials, training and residency detail
- Prices a daily oral route for both molecules alongside the weekly injections
The tradeoffs
- Three sets of prices are live at once: $198 and $210 in the hero, $229 and $279 in the same pages' own FAQ headings, and a third set in the site's JavaScript
- The FAQ's own arithmetic does not reach the headline — $99 membership plus $130 medication is $229, not the $198 quoted above it
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.